Group 1 - The Hong Kong stock market experienced a correction today, with the Hong Kong Stock Connect Innovative Drug ETF (159570) falling over 2% and marking a three-day decline [1] - The trading volume for the ETF reached 763 million yuan, with an increase of 903 million shares traded in the past month [1] - Other related ETFs also showed declines, including the E Fund Hong Kong Consumption ETF (513070) down 1.12%, the Hong Kong Automotive ETF (159210) down 0.71%, the Hong Kong Stock Connect Non-Bank ETF (513750) down 0.67%, and the Hong Kong Stock Connect Technology 30 ETF (520980) down 0.46% [1] Group 2 - The mentioned ETFs allow investment in the Hong Kong market without the need for a Hong Kong stock account [1]

Market Overview - The Hong Kong stock market experienced a correction this week, with the Hang Seng Index declining by 3.5%, the Hang Seng China Enterprises Index down by 3.8%, and the CSI Hong Kong Stock Connect China 100 Index falling by 3.3% [1][3]. Fund Flows - Southbound funds were actively increasing their positions, with a total net purchase of nearly 60 billion yuan [1]. Index Performance - The rolling price-to-earnings (P/E) ratios for the indices are as follows: Hang Seng Index at 11.3 times, Hang Seng China Enterprises Index at 10.2 times, and CSI Hong Kong Stock Connect China 100 Index at 10.7 times [3]. - The rolling P/E ratio percentiles indicate that the Hang Seng Index is at 50.4%, the Hang Seng China Enterprises Index at 62.3%, and the CSI Hong Kong Stock Connect China 100 Index at 87.6% [3]. Sector Composition - The CSI Hong Kong Stock Connect China 100 Index comprises 100 large-cap and actively traded companies from mainland China, with financials, consumer discretionary, and information technology sectors accounting for over 65% of the index [6]. - The broader index sectors, including consumer discretionary, financials, information technology, and energy, collectively represent over 85% of the index [6]. Historical Performance - Year-to-date performance shows the Hang Seng Index up by 22.2%, the Hang Seng China Enterprises Index up by 20.8%, and the CSI Hong Kong Stock Connect China 100 Index up by 23.7% [7]. - Over the past year, the Hang Seng Index has increased by 44.6%, the Hang Seng China Enterprises Index by 47.4%, and the CSI Hong Kong Stock Connect China 100 Index by 49.9% [7].

由天天基金独家播出的《下半年配置诊疗室》直播特别策划现已正式上线！ 长按下方二维码 或 点击文末阅 读原文 提前锁定心仪场次，预约直播不迷路！ 更有京东卡、遮阳伞等大量好礼等你来抽~ 下周一（8月4日），鹏华基金、东方基金将带来两场直播，讲述下半年港股、黄金的投资机会，欢迎一键预约观看哦~ 主题：《掘金港股大消费+硬科技+医药新势力！》 8月4日（周一）14：00 预约查看更多直播 还有好礼等你赢！ 免责声明 以上观点来自相关机构，不代表天天基金的观点，不对观点的准确性和完整性做任何保证。 收益率数据仅供参考，过往业绩和走势风格不预示未来表现，不构成投资建议。转引的相关 ↓ 点击"阅读原文" 时间：8月4日 14：00 点击下方链接即可预约↓ 8月4日（周一）15：00 主题：《资产配置压舱石，黄金还能买吗？》 时间：8月4日 15：00 点击下方链接即可预约↓ 分享、点赞、在看 顺手三连越来越有钱 ...

Group 1: Market Overview - On July 31, the Hong Kong stock market saw a net inflow of 13.126 billion HKD from northbound trading, with 7.604 billion HKD from Shanghai and 5.522 billion HKD from Shenzhen [2] - The most bought stocks included Yingfu Fund (02800), Hang Seng China Enterprises (02828), and Meituan-W (03690), while the most sold stocks were Laopu Gold (06181), CSPC Pharmaceutical Group (01093), and Shandong Molong (00568) [2][6] Group 2: Stock Performance - Meituan-W (03690) had a net buy amount of 2.622 billion HKD, while Laopu Gold (06181) faced a net sell of 2.78 billion HKD [3][7] - CSPC Pharmaceutical Group (01093) had a net sell of 891.29 million HKD, indicating a significant outflow [4][7] Group 3: Company Insights - Laopu Gold (06181) is expected to see a 26% year-on-year revenue growth next year, with adjusted net profit projected to rise by 30% [7] - The company plans to open six new boutique stores, with a projected 6% year-on-year increase in sales per store [7] - The target price for Laopu Gold has been adjusted down by 4% to 958 HKD, maintaining a "buy" rating despite concerns over sustainable profit growth [7] Group 4: Sector Analysis - The Hong Kong market is experiencing a robust inflow of funds, with a focus on technology and new consumption sectors, which are considered relatively scarce assets [5] - The technology sector is highlighted as a significant part of the Hong Kong market, accounting for nearly one-third, with ongoing revaluation expected [6]

| 1 / 1 | | | | | | | --- | --- | --- | --- | --- | --- | | 排名 | 殷景代碼 | 名桐 | 買入金額 (HKD) | 賈出金額 (HKD) | 黄人及霞出金额(HKD) | | 1 | 03690 | 美露 - W | 2,622,274,620 | 1,426,324,769 | 4,048,599,389 | | 2 | 09988 | 同里巴巴 - W | 2,221,660,110 | 1,568,114,624 | 3,789,774,734 | | 3 | 01810 | 小米塩圆 - W | 2,031,169,230 | 1,663,169,075 | 3,694,338,305 | | 4 | | 00700 滕田控股 | 1,770,165,250 | 1,673,517,070 | 3,443,682,320 | | 5 | 00981 | 中芯圆膜 | 1,549,775,325 | 1,651,186,685 | 3,200,962,010 | | 6 | 01024 | 快手 - W | 1,500,686,990 | ...

Group 1: Market Overview - On July 31, the Hong Kong stock market saw a net inflow of 13.126 billion HKD from northbound trading, with 7.604 billion HKD from the Shanghai Stock Connect and 5.522 billion HKD from the Shenzhen Stock Connect [2] - The most bought stocks included the Tracker Fund of Hong Kong (02800), Hang Seng China Enterprises (02828), and Meituan-W (03690) [2][3] - The most sold stocks were Laopuhuangjin (06181), CSPC Pharmaceutical Group (01093), and Shandong Molong Petroleum Machinery (00568) [2] Group 2: Active Stocks - The top net bought stocks included Meituan-W (03690) with 2.622 billion HKD, Alibaba-W (09988) with 2.222 billion HKD, and Xiaomi Group-W (01810) with 2.031 billion HKD [3] - The top net sold stocks included Shandong Molong (00568) with 940 million HKD and CSPC Pharmaceutical Group (01093) with 891 million HKD [3] Group 3: ETF and Sector Insights - Northbound trading showed strong interest in ETFs, with the Tracker Fund of Hong Kong (02800) receiving a net inflow of 2.405 billion HKD, Hang Seng China Enterprises (02828) with 1.781 billion HKD, and Southern Hang Seng Technology (03033) with 973 million HKD [6] - The technology sector is highlighted as a significant part of the Hong Kong market, accounting for nearly one-third, with a focus on potential revaluation driven by technology [6] Group 4: Company-Specific News - Meituan-W (03690) received a net inflow of 13.98 billion HKD, while Kuaishou-W (01024) and Alibaba-W (09988) received 13.82 billion HKD and 10.43 billion HKD respectively [6] - Semiconductor company SMIC (00981) saw a net inflow of 2.21 billion HKD amid concerns regarding Nvidia's chip security issues [7] - Meitu Company (01357) received a net inflow of 15.3 million HKD, with Morgan Stanley raising its target price by 140% [7] Group 5: Performance Expectations - Laopuhuangjin (06181) faced a net outflow of 2.78 billion HKD, with analysts questioning the sustainability of its profit growth [8] - Analysts expect Laopuhuangjin's revenue to grow by 26% year-on-year next year, with adjusted net profit expected to rise by 30% [8] - Xiaomi Group-W (01810) received a net inflow of 441 million HKD, while CSPC Pharmaceutical Group (01093) and Shandong Molong (00568) faced net outflows [8]

本文源自：金融界AI电报 金融界7月31日消息，周四，港股集体低开，盘面上，创新药概念股走高，截至10：00，港股通科技 ETF（513860）小幅回调，该基金自7月以来累计涨超7%，年内至今累计涨近40%！ 热门个股方面，美 图公司涨超6%，东方甄选、科伦博生物-B等涨超4%，微创医疗等涨超3%、迈富时、金山云、快手- W、金蝶国际、三生制药等涨超2%。 资金净流入方面来看，Wind数据统计，截至最新收盘日，港股通 科技ETF（513860）近8个交易日连续获得场外基金净申购，昨日获得资金净流入额1.3亿元，近20天累 计获得资金净流入额7.4亿元，资金加速布局！ 消息面上，据中国证券报，截至7月28日，7月以来已有 620家上市公司接待机构调研。从二级市场表现看，近八成被调研的公司7月以来取得正收益。从行业偏 好看，其中医药生物行业有66家公司接待机构调研，创新药、创新器械方向的机遇值得关注。 光大证 券认为，港股整体盈利能力相对较强，同时互联网、新消费、创新药等资产相对稀缺，结合当前估值仍 偏低，长期配置性价比仍较高。近期恒生指数已经突破了前期高点，上涨阻力较小，在国内稳增长政策 的持续发力下，港股市场 ...

Market Overview - The Hong Kong stock market experienced a correction today, with total trading volume nearing HKD 320 billion [1] - Southbound funds continued to increase their positions, with a net purchase of HKD 11.71 billion during the day [1] - The Hang Seng Index fell by 1.4%, the Hang Seng China Enterprises Index decreased by 1.2%, and the CSI Hong Kong Stock Connect China 100 Index dropped by 1.1% [1] ETF Performance - The Hang Seng ETF (E Fund) tracks the Hang Seng Index, which consists of large-cap, actively traded stocks with strong industry representation, covering nearly 80% of the financial, consumer discretionary, and information technology sectors. The index declined by 1.4% with a rolling P/E ratio of 11.5 times, representing a valuation percentile of 52.2% since 2002 [2] - The HAGETF tracks the Hang Seng China Enterprises Index, composed of 50 large-cap, actively traded stocks from mainland China listed in Hong Kong. The index fell by 1.2% with a rolling P/E ratio of 10.5 times, indicating a valuation percentile of 64.1% since 2002 [2] - The Hong Kong Stock Connect 100 ETF tracks the CSI Hong Kong Stock Connect China 100 Index, which includes 100 large-cap, actively traded mainland Chinese companies within the Stock Connect framework. The index decreased by 1.1% with a rolling P/E ratio of 11.0 times, reflecting a valuation percentile of 91.2% since 2020 [2]

Group 1: Capital Market Trends - The A-share market is showing signs of continuous optimization, with trading volume exceeding 1 trillion yuan for 44 consecutive days and nearly 700 companies engaging in buybacks [1] - The China Securities Regulatory Commission (CSRC) aims to stabilize and activate the capital market, focusing on creating a market ecosystem that rewards investors and promotes innovation [1] Group 2: Mergers and Acquisitions - In the first half of the year, the State Administration for Market Regulation concluded 339 cases of operator concentration, a year-on-year increase of 14.1%, indicating active domestic mergers and acquisitions [2] - The total transaction amount for these cases exceeded 1.3 trillion yuan, with significant activity in the automotive and chemical raw materials sectors [2] Group 3: Hong Kong Market Performance - Southbound capital has seen a record net inflow of over 840 billion HKD this year, significantly contributing to the positive performance of the Hong Kong stock market, with the Hang Seng Index rising over 27% [3] - Major stocks like Xiaomi and Tencent have shown substantial gains, with Xiaomi increasing over 60% and Tencent over 34% [3] Group 4: State-Owned Enterprises - The establishment of China Chang'an Automobile Group in Chongqing marks the formation of a new central enterprise in the automotive sector, aimed at enhancing competitiveness and supporting the development of smart and connected new energy vehicles [4] Group 5: Securities Firms' Strategies - Securities firms are focusing on regional economic services, business transformation, and digital innovation as key areas for development in the second half of the year [5] Group 6: Asset Management Trends - In July, several large overseas China stock ETFs attracted over 2.7 billion USD, reflecting growing interest from foreign investors in Chinese assets [6][7] Group 7: Share Buybacks - Listed companies have repurchased nearly 90 billion yuan worth of shares this year, with July alone seeing buybacks of 14.01 billion yuan, marking a 12.06% increase from the previous month [8] Group 8: Corporate Performance - Among the companies that reported positive performance in the first half of the year, 31 stocks have a rolling P/E ratio below 30, indicating potential undervaluation [9] Group 9: Economic Outlook - The International Monetary Fund (IMF) has significantly raised its growth forecast for China's economy, citing stronger-than-expected economic activity in the first half of the year [10] Group 10: Asset Securitization - The asset securitization market is expanding, with the largest corporate ABS product issued this year reaching 10.01 billion yuan, contributing to a total issuance of 714.08 billion yuan across 807 products [11] Group 11: Stock Ratings Adjustments - In July, securities firms adjusted ratings for 25 stocks upward, reflecting the impact of companies' performance in the first half of the year [12] Group 12: Small Metals Sector Performance - Companies in the small metals sector, such as Northern Rare Earth and Zhejiang Huayou Cobalt, reported significant profit increases, with Northern Rare Earth expecting a net profit growth of over 1882% [14]

Core Insights - The number of QDII funds in China reached 319 with a total scale of 683.77 billion yuan, marking an 11.85% increase from the end of last year, a historical high [1][2] - Significant growth in QDII fund shares investing in the Hong Kong stock market, with eight out of the top ten funds by share increase being QDII funds focused on Hong Kong stocks [2] - The Hong Kong technology-themed QDII funds saw remarkable share increases, particularly index funds, with the largest being the Huaxia Hang Seng Technology ETF, which increased by 9.51 billion shares [2] QDII Fund Growth - As of the end of June, QDII funds' total scale reached 683.77 billion yuan, a historical high [1][2] - The share of QDII funds investing in Hong Kong stocks significantly increased, with eight funds in the top ten for share growth [2] - The Huaxia Hang Seng Technology ETF had a share increase of 9.51 billion, leading the market [2] Global Fund Allocation - There is a growing trend in domestic funds for global allocation, with several funds like the Bosera S&P 500 ETF and Huaxia Nasdaq 100 ETF showing notable share increases [3] Domestic Fund Holdings in Hong Kong - As of July 28, net inflows from southbound funds reached 772.19 billion yuan, surpassing the total for the entire year of 2024 [4] - The number of domestic public funds investing in Hong Kong stocks increased to 4,048, with total assets reaching 2.62 trillion yuan [4] - The stock market value held by public funds in Hong Kong reached 734.3 billion yuan, a 12.8% increase [4] Outlook on Hong Kong Market - The Hong Kong market has rebounded significantly, with the Hang Seng Index and Hang Seng Technology Index rising by 27.43% and 26.77% respectively [5] - Fund managers maintain an optimistic outlook on the Hong Kong market, citing signs of economic recovery and the presence of globally competitive Chinese companies [6]